MTNB

Matinas Biopharma Holdings Inc
0.56
0.017 (3.13%)

Matinas Biopharma Holdings Inc. (MTNB) Fundamentals

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
SHARE INFORMATION
Market Cap$ 123,374,229
Shares Outstanding216,864,526
Float208,610,899
Percent Float96.19%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 33,333
Latest Fiscal EPS$ -0.11
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions86
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,474,922
Institutional Holdings Percent24.7%
Institutional Sold Previous 3 Months406,880
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months5,819,242
Insider Holdings Percent5.2
Insider Sold Previous 3 Months-
Insider Shares Owned11,259,733
TRADING INFO
52 Week High$ 1.00
52 Week Low$ 0.43
52 Week High Change$ -20.94
21 Day Moving Average$ 0.564
21 Day Extended Moving Average$ 0.568644
50 Day Moving Average$ 0.5804
50 Day Extended Moving Average$ 0.590063
200 Day Moving Average$ 0.712692
200 Day Extended Moving Average$ 0.697033
10 Day Average Volume255,685
20 Day Average Volume272,732
30 Day Average Volume363,677
50 Day Average Volume434,055
Alpha0.012682
Beta2.0420
Standard Deviation0.298118
R20.136882
7 Day Price Change$ -0.0211
7 Day Percent Change-3.58%
21 Day Price Change$ 0.0189
21 Day Percent Change3.44%
30 Day Price Change$ 0.0689
30 Day Percent Change13.78%
Month to Date Price Change$ -0.0076
Month to Date Percent Change-1.32%
Quarter to Date Price Change$ 0.0689
Quarter to Date Percent Change13.78%
180 Day Price Change$ -0.302
180 Day Percent Change-34.68%
200 Day Price Change$ -0.2451
200 Day Percent Change-30.11%
Year to Date Price Change$ 0.0689
Year to Date Percent Change13.78%

Matinas Biopharma Holdings Inc. (MTNB) Key Ratios

PROFITABILITY
EBIT Margin-1,215.3%
EBITDA Margin-1,174.0%
Pre-Tax Profit Margin-25,227.9%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,125,000
Revenue Per Share$ 0.0098
Revenue (3 Years)$ 76.52
Revenue (5 Years)$ 19.33
FINANCIAL STRENGTH
Price to Tangible Book3.40
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio7.60
Leverage Ratio1.20
Quick Ratio6.70
Long Term Debt To Capital0.09
VALUATION MEASURES
PE Ratio-4.50
Enterprise Value$ 88,938,469
Price to Sales58.0585
Price to Free Cash-7.50
PE High Last 5 Years-4.00
Price To Book3.10
Price To Cash Flow0.00
PE Low Last 5 Years-5.60
Price to Tangible Book3.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-42.02
Return on Equity-49.68
Return on Capital-45.43

Matinas Biopharma Holdings Inc. (MTNB) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorEisnerAmper LLP
CEOJerome D. Jabbour
Emplyoees31
Last AuditUQ
CIK0001582554
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1545 Route 206 South
Suite 302
Bedminster, NJ 7921
Websitehttps://www.matinasbiopharma.com
Facsimile-
Telephone+1 908 484-8805
Emailicooney@matinasbiopharma.com


Your Recent History
AMEX
MTNB
Matinas Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.